Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images)

Tem­pus founders build a drug dis­cov­ery start­up, Pathos AI, with $40M in sight

Ex­ec­u­tives be­hind AI and pre­ci­sion med­i­cine start­up Tem­pus are putting to­geth­er an­oth­er AI out­fit in Chica­go fo­cused on on­col­o­gy drug dis­cov­ery and de­vel­op­ment.

Pathos AI …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.